speb/financial-data huggingface dataset:
Financial ratios for BFS — annual report dated 2025-12-31
Total revenue: 289843000
Gross profit: 205363000
Operating income: 119647000
Net income: 49219000
Capital expenditures: 0
Operating cash flow: 99796000
Depreciation & amortization: 58784000
Net tangible assets: 307820000
Owner earnings: 108003000
Return on net tangible assets (%): 35.086414138132675
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.42
P/E ratio: 15.164414808915257
Shares outstanding: 24535744
Book value: 477257000
P/B ratio: 1.563889754325238
Market cap (USD): 746377332.48
Debt to equity: 3.356267168422883
Current ratio: 0.3384649829404693
Quick ratio: 0.3384649829404693
Interest coverage ratio: 1.7661116523484781
COGS to revenue (%): 29.14681396480163
SG&A to revenue (%): 9.291927008759915
Free cash flow (dilution-adjusted): 97813000
Buyback yield (%): 0
Retained earnings: -337708000
Receivables turnover: 4.767233013700883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.113106286924165
FCF margin (%): 33.74689055799174
Revenue growth (%): 7.8096463787953745
Rule of 40 score: 41.55653693678711
Financial ratios for BFS — quarterly report dated 2025-12-31
Total revenue: 75149000
Gross profit: 52013000
Operating income: 28109000
Net income: 8194000
Capital expenditures: 0
Operating cash flow: 22187000
Depreciation & amortization: 16057000
Net tangible assets: 307820000
Owner earnings: 24251000
Return on net tangible assets (%): 7.878305503216165
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 30.42
P/E ratio: 15.164414808915257
Shares outstanding: 24535744
Book value: 477257000
P/B ratio: 1.563889754325238
Market cap (USD): 746377332.48
Debt to equity: 3.356267168422883
Current ratio: 0.3384649829404693
Quick ratio: 0.3384649829404693
Interest coverage ratio: 1.4717524477721347
COGS to revenue (%): 30.786836817522524
SG&A to revenue (%): 10.441922048197581
Free cash flow (dilution-adjusted): 21633000
Buyback yield (%): 0
Retained earnings: -337708000
Receivables turnover: 1.23602361880952
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4361689354446943
FCF margin (%): 28.786810203728592
Revenue growth (%): 4.367812899283373
Rule of 40 score: 33.154623103011964
Financial ratios for BKT.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.920454545454546
Shares outstanding: 898696272
Market cap (USD): 3523297884.545455
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKT.MC — annual report dated 2022-12-31
Total revenue: 2406619148.9361706
Net income: 595960638.2978724
Capital expenditures: 14848936.170212766
Operating cash flow: -8547846808.510639
Depreciation & amortization: 85200000
Net tangible assets: 4921310638.297873
Owner earnings: 666311702.1276597
Return on net tangible assets (%): 13.539314038467525
Buffett classification: The Gruesome
Stock price: 5.351063829787234
P/E ratio: 8.069293181507417
Shares outstanding: 898696272
Book value: 5218055319.148926
P/B ratio: 0.9216040882924529
Market cap (USD): 4808981115.06383
Debt to equity: 1.5879648242640358
Effective tax rate (%): 28.639923978105493
COGS to revenue (%): 0
SG&A to revenue (%): 12.883704605471966
Free cash flow (dilution-adjusted): -8624708510.638298
Buyback yield (%): 1.8686003572854457
Retained earnings: 5283995744.680851
Receivables turnover: 18.00530077521848
Capitalized R&D asset: 0
FCF margin (%): -358.37446545918124
Rule of 40 score: -358.37446545918124
Financial ratios for BKT.MC — annual report dated 2023-12-31
Total revenue: 3237462222.2222223
Net income: 938652222.2222222
Capital expenditures: 13925555.555555556
Operating cash flow: 731576666.6666666
Depreciation & amortization: 91187777.77777778
Net tangible assets: 5578804444.444445
Owner earnings: 1015914444.4444444
Return on net tangible assets (%): 18.2102537301899
Buffett classification: The Gruesome
Stock price: 5.6
P/E ratio: 5.361622765123043
Shares outstanding: 898696272
Book value: 5914377777.777786
P/B ratio: 0.8509262195102694
Market cap (USD): 5032699123.2
Debt to equity: 1.7784707323396443
Effective tax rate (%): 31.25329579115263
COGS to revenue (%): 0
SG&A to revenue (%): 10.709897601550734
Free cash flow (dilution-adjusted): 631152222.2222222
Buyback yield (%): 1.7467763887323975
Retained earnings: 6105648888.888888
Receivables turnover: 19.84333542183116
Capitalized R&D asset: 0
FCF margin (%): 19.495276821763
Revenue growth (%): 34.523247006212856
Rule of 40 score: 54.018523827975855
Financial ratios for BKT.MC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.9
Shares outstanding: 898696272
Market cap (USD): 7099700548.8
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKT.MC — annual report dated 2024-12-31
Total revenue: 3210823958.3333335
Net income: 992678125
Capital expenditures: 47564583.333333336
Operating cash flow: 2022336458.3333335
Depreciation & amortization: 91096875
Net tangible assets: 5788769791.666667
Owner earnings: 1036210416.6666666
Return on net tangible assets (%): 17.900356275324043
Buffett classification: The Gruesome
Stock price: 7.416666666666667
P/E ratio: 6.714493365107648
Shares outstanding: 898696272
Book value: 6122567708.333328
P/B ratio: 1.088649566901143
Market cap (USD): 6665330684
Debt to equity: 1.651416846655944
Effective tax rate (%): 29.913039513186018
COGS to revenue (%): 0
SG&A to revenue (%): 10.778807750217283
Free cash flow (dilution-adjusted): 1864939583.3333335
Buyback yield (%): 1.2296839254614844
Retained earnings: 6255696875
Receivables turnover: 20.36261601981833
Capitalized R&D asset: 0
FCF margin (%): 58.08289733521802
Revenue growth (%): -0.822813119054841
Rule of 40 score: 57.26008421616318
Financial ratios for BKT.MC — quarterly report dated 2024-12-31
Total revenue: 796116666.6666667
Net income: 231169791.6666667
Capital expenditures: 0
Net tangible assets: 5788769791.666667
Owner earnings: 231169791.6666667
Return on net tangible assets (%): 3.9934182906954003
Buffett classification: The Gruesome
Stock price: 7.416666666666667
P/E ratio: 7.208263064936936
Shares outstanding: 898696272
Book value: 6122567708.333328
P/B ratio: 1.088649566901143
Market cap (USD): 6665330684
Debt to equity: 1.651416846655944
Effective tax rate (%): 19.917219080749284
COGS to revenue (%): 0
SG&A to revenue (%): 16.703215609102518
Buyback yield (%): 0
Retained earnings: 6255696875
Receivables turnover: 5.048865400495458
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BKT.MC — quarterly report dated 2025-03-31
Total revenue: 809642391.3043478
Net income: 293625000
Capital expenditures: 0
Net tangible assets: 6227029347.826087
Owner earnings: 293625000
Return on net tangible assets (%): 4.715330273856942
Buffett classification: The Gruesome
Stock price: 10.380434782608695
P/E ratio: 7.942833580987284
Shares outstanding: 898696272
Book value: 6572376086.956512
P/B ratio: 1.4194041724702189
Market cap (USD): 9328858040.869564
Debt to equity: 1.534730176664983
Effective tax rate (%): 28.615785468152122
COGS to revenue (%): 0
SG&A to revenue (%): 14.961785329271782
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1.6989626274642753
Rule of 40 score: 1.6989626274642753
Financial ratios for BKT.MC — quarterly report dated 2025-06-30
Total revenue: 933192941.1764706
Net income: 319480000
Capital expenditures: 0
Net tangible assets: 6926697647.058824
Owner earnings: 319480000
Return on net tangible assets (%): 4.612298908927487
Buffett classification: The Gruesome
Stock price: 12.470588235294118
P/E ratio: 13.274435370244587
Shares outstanding: 898696272
Book value: 7307534117.647064
P/B ratio: 1.5336597785621406
Market cap (USD): 11207271156.705883
Debt to equity: 1.6367726201676775
Effective tax rate (%): 29.869660321420184
COGS to revenue (%): 0
SG&A to revenue (%): 8.068440546939414
Buyback yield (%): 0
Retained earnings: 7112775294.117647
Capitalized R&D asset: 0
Revenue growth (%): 15.259891428496083
Rule of 40 score: 15.259891428496083
Financial ratios for BKT.MC — annual report dated 2025-12-31
Total revenue: 3680501176.470588
Net income: 1282324705.882353
Capital expenditures: 40881176.47058824
Operating cash flow: -704567058.8235295
Depreciation & amortization: 106303529.41176471
Net tangible assets: 7106562352.941176
Owner earnings: 1347747058.8235295
Return on net tangible assets (%): 18.964824227085554
Buffett classification: The Gruesome
Stock price: 16.28235294117647
P/E ratio: 11.41122043465177
Shares outstanding: 898696272
Book value: 7542922352.941193
P/B ratio: 1.9399496909732556
Market cap (USD): 14632889887.62353
Debt to equity: 1.8624153160173174
Effective tax rate (%): 29.000024752829965
COGS to revenue (%): 0
SG&A to revenue (%): 10.678085401412723
Free cash flow (dilution-adjusted): -901904705.882353
Buyback yield (%): 0.3712506982527127
Retained earnings: 7751596470.588236
Receivables turnover: 21.54815646459985
Capitalized R&D asset: 0
FCF margin (%): -24.504942741173995
Revenue growth (%): 14.627934269590215
Rule of 40 score: -9.87700847158378
Financial ratios for BKT.MC — quarterly report dated 2025-12-31
Total revenue: 949392941.1764706
Net income: 327607058.8235294
Capital expenditures: 0
Net tangible assets: 7106562352.941176
Owner earnings: 327607058.8235294
Return on net tangible assets (%): 4.609923090141374
Buffett classification: The Gruesome
Stock price: 16.28235294117647
P/E ratio: 12.486659710194004
Shares outstanding: 898696272
Book value: 7542922352.941193
P/B ratio: 1.9399496909732556
Market cap (USD): 14632889887.62353
Debt to equity: 1.8624153160173174
Effective tax rate (%): 28.98540006375518
COGS to revenue (%): 0
SG&A to revenue (%): 15.165108601905363
Buyback yield (%): 0
Retained earnings: 7751596470.588236
Receivables turnover: 5.558391822734067
Capitalized R&D asset: 0
Revenue growth (%): 1.735975411427433
Rule of 40 score: 1.735975411427433
Financial ratios for BOQ.AX — annual report dated 2021-08-31
Total revenue: 908029197.0802919
Net income: 269343065.69343066
Capital expenditures: 2189781.02189781
Operating cash flow: 278102189.7810219
Depreciation & amortization: 65693430.6569343
Net tangible assets: 3643065693.4306564
Owner earnings: 332846715.3284672
Return on net tangible assets (%): 9.136445602083754
Buffett classification: The Gruesome
Stock price: 5.145985401459853
P/E ratio: 12.561760691056909
Shares outstanding: 657487900
Book value: 4523357664.233574
P/B ratio: 0.7479893004679687
Market cap (USD): 3383423135.036496
Debt to equity: 2.8599322252702932
Effective tax rate (%): 31.412639405204462
COGS to revenue (%): 0
SG&A to revenue (%): 7.07395498392283
Free cash flow (dilution-adjusted): 184671532.8467153
Buyback yield (%): 0.15101537251384242
Retained earnings: 214598540.1459854
Capitalized R&D asset: 0
FCF margin (%): 20.337620578778136
Rule of 40 score: 20.337620578778136
Financial ratios for BOQ.AX — annual report dated 2022-08-31
Total revenue: 1128767123.2876713
Net income: 280136986.30136985
Capital expenditures: 24657534.246575344
Operating cash flow: -847260273.9726027
Depreciation & amortization: 89041095.89041096
Net tangible assets: 3706164383.561644
Owner earnings: 344520547.94520545
Return on net tangible assets (%): 9.29587876547773
Buffett classification: The Gruesome
Stock price: 3.780821917808219
P/E ratio: 8.873675325183374
Shares outstanding: 657487900
Book value: 4567123287.671234
P/B ratio: 0.5442911229754047
Market cap (USD): 2485844663.0136986
Debt to equity: 2.8774745050989794
Effective tax rate (%): 31.94675540765391
COGS to revenue (%): 0
SG&A to revenue (%): 6.007281553398059
Free cash flow (dilution-adjusted): -990410958.9041096
Buyback yield (%): 0.4684056003049693
Retained earnings: 209589041.0958904
Capitalized R&D asset: 0
FCF margin (%): -87.74271844660193
Revenue growth (%): 24.309562612870568
Rule of 40 score: -63.43315583373136
Financial ratios for BOQ.AX — annual report dated 2023-08-31
Total revenue: 1138961038.9610388
Net income: 80519480.51948051
Capital expenditures: 649350.6493506493
Operating cash flow: 2315584415.5844154
Depreciation & amortization: 94805194.80519481
Net tangible assets: 3284415584.4155846
Owner earnings: 174675324.67532468
Return on net tangible assets (%): 5.318307631474891
Buffett classification: The Gruesome
Stock price: 3.1363636363636362
P/E ratio: 25.61021416935484
Shares outstanding: 657487900
Book value: 3980519480.5194855
P/B ratio: 0.5180532719412717
Market cap (USD): 2062121140.9090908
Debt to equity: 3.1520391517128834
Effective tax rate (%): 55.871886120996436
COGS to revenue (%): 0
SG&A to revenue (%): 5.359179019384265
Free cash flow (dilution-adjusted): 2220779220.7792206
Buyback yield (%): 0.5353206860628221
Retained earnings: 244155844.15584415
Capitalized R&D asset: 0
FCF margin (%): 194.98289623717218
Revenue growth (%): 0.9031017526162954
Rule of 40 score: 195.88599798978848
Financial ratios for BOQ.AX — annual report dated 2024-08-31
Total revenue: 1086394557.8231292
Net income: 193877551.02040815
Capital expenditures: 0
Operating cash flow: -588435374.1496599
Depreciation & amortization: 82993197.27891156
Net tangible assets: 3302721088.4353743
Owner earnings: 276870748.29931974
Return on net tangible assets (%): 8.383110195674561
Buffett classification: The Gruesome
Stock price: 3.857142857142857
P/E ratio: 13.080548747368422
Shares outstanding: 657487900
Book value: 4093197278.9115677
P/B ratio: 0.6195706154229679
Market cap (USD): 2536024757.142857
Debt to equity: 3.050855908259928
Effective tax rate (%): 35.079726651480634
COGS to revenue (%): 0
SG&A to revenue (%): 6.637445209768317
Free cash flow (dilution-adjusted): -711564625.8503401
Buyback yield (%): 0.21459478482692648
Retained earnings: 247619047.6190476
Capitalized R&D asset: 0
FCF margin (%): -65.49780839073263
Revenue growth (%): -4.615301080523425
Rule of 40 score: -70.11310947125605
Financial ratios for BOQ.AX — quarterly report dated 2025-02-28
Capital expenditures: 0
Net tangible assets: 3046250000
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 657487900
Book value: 3782500000
P/B ratio: 0.6692209953734304
Market cap (USD): 2531328415
Debt to equity: 2.8103106411103767
Buyback yield (%): 0
Retained earnings: 209375000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWAY — annual report dated 2021-12-31
Capital expenditures: 721935.4838709678
Depreciation & amortization: 151935.48387096773
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 40129409
Market cap (USD): 154498224.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWAY — annual report dated 2022-12-31
Total revenue: 7720738.636363637
Gross profit: 5695454.545454546
Operating income: -3603125
Net income: -3792329.5454545454
Capital expenditures: 550000
Operating cash flow: -2772727.272727273
Depreciation & amortization: 435795.45454545453
Net tangible assets: 12896875
Owner earnings: -3906534.090909091
Return on net tangible assets (%): -30.290547833557284
Buffett classification: The Gruesome
Stock price: 1.24
Shares outstanding: 40129409
Book value: 12896875
P/B ratio: 3.858335229270657
Market cap (USD): 49760467.16
Debt to equity: 0.010749609005000332
Current ratio: 7.1353642058715145
Quick ratio: 6.664046185972239
Interest coverage ratio: -275.7173913043478
COGS to revenue (%): 26.231740074327554
R&D to revenue (%): 28.25183059204474
SG&A to revenue (%): 89.4763954814733
Free cash flow (dilution-adjusted): -3191477.272727273
Buyback yield (%): 0.029687678022047075
Retained earnings: -27586647.727272727
Inventory turnover: 1.8579619494396664
Receivables turnover: 5.610445912469035
Capitalized R&D asset: 2181250
ROCI (R&D-adjusted, %): -11.816685933285427
FCF margin (%): -41.3364241822129
Rule of 40 score: -41.3364241822129
Financial ratios for BWAY — annual report dated 2023-12-31
Total revenue: 8780386.740331491
Gross profit: 6485359.116022099
Operating income: -1369889.5027624308
Net income: -1159392.2651933702
Capital expenditures: 659392.2651933702
Operating cash flow: 354696.1325966851
Depreciation & amortization: 369337.01657458564
Net tangible assets: 11486464.08839779
Owner earnings: -1449447.5138121548
Return on net tangible assets (%): -12.61874413794762
Buffett classification: The Gruesome
Stock price: 3.24
Shares outstanding: 40129409
Book value: 11486464.08839779
P/B ratio: 11.319348074341647
Market cap (USD): 130019285.16000001
Debt to equity: 0.011327288905990716
Current ratio: 5.682307140661817
Quick ratio: 5.301505993238397
Interest coverage ratio: -103.3125
COGS to revenue (%): 26.138115463268836
R&D to revenue (%): 20.969010539562685
SG&A to revenue (%): 68.07613654239421
Free cash flow (dilution-adjusted): -409944.75138121546
Buyback yield (%): 0
Retained earnings: -27983977.900552485
Inventory turnover: 2.2351358622545066
Receivables turnover: 8.408730158730158
Capitalized R&D asset: 3302597.7209944753
ROCI (R&D-adjusted, %): -4.830262454575504
Rosenberg metric: 0.3621339005467291
FCF margin (%): -4.668868963347491
Revenue growth (%): 13.724698553802291
Rule of 40 score: 9.055829590454799
Financial ratios for BWAY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.62
Shares outstanding: 40129409
Market cap (USD): 185397869.58
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWAY — quarterly report dated 2024-12-31
Capital expenditures: 252876.71232876714
Buffett classification: The Gruesome
Stock price: 4.72
Shares outstanding: 40129409
Market cap (USD): 189410810.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BWAY — annual report dated 2024-12-31
Total revenue: 11237260.273972603
Gross profit: 8378356.164383562
Operating income: 381095.8904109589
Net income: 800273.9726027397
Capital expenditures: 1039452.0547945206
Operating cash flow: 2821369.8630136987
Depreciation & amortization: 485205.47945205483
Net tangible assets: 17072054.79452055
Owner earnings: 246027.3972602738
Return on net tangible assets (%): 1.441111806525122
Capex to operating income (%): 272.7534148094896
Buffett classification: The Gruesome
Stock price: 4.72
P/E ratio: 236.68245746388226
Shares outstanding: 40129409
Book value: 17072054.79452055
P/B ratio: 11.094786934540142
Market cap (USD): 189410810.48
Debt to equity: 0.09025404008794313
Current ratio: 5.191580867978626
Quick ratio: 4.903166949042096
Effective tax rate (%): 15.553628216247473
Interest coverage ratio: 0.9175461741424802
COGS to revenue (%): 25.441291203432808
R&D to revenue (%): 17.52974448995514
SG&A to revenue (%): 53.637604837136735
Free cash flow (dilution-adjusted): 1387123.2876712328
Buyback yield (%): 0
Retained earnings: -26953698.630136985
Inventory turnover: 2.3576592860370535
Receivables turnover: 8.924281984334202
Capitalized R&D asset: 3923252.8617649283
ROCI (R&D-adjusted, %): 1.383216481112276
Rosenberg metric: 1.028154435869242
FCF margin (%): 12.343963331382875
Revenue growth (%): 27.981381758001646
Rule of 40 score: 40.32534508938452
Financial ratios for BWAY — quarterly report dated 2025-03-31
Total revenue: 3126287.262872629
Gross profit: 2333333.3333333335
Operating income: 156097.56097560975
Net income: 300000
Capital expenditures: 282655.8265582656
Operating cash flow: 1357723.5772357723
Depreciation & amortization: 106775.06775067751
Net tangible assets: 17276422.764227644
Owner earnings: 124119.24119241192
Return on net tangible assets (%): 0.7184313725490196
Capex to operating income (%): 181.0763888888889
Buffett classification: The Gruesome
Stock price: 4.74
P/E ratio: 158.51116555000002
Shares outstanding: 40129409
Book value: 17276422.764227644
P/B ratio: 11.009999075378822
Market cap (USD): 190213398.66
Debt to equity: 0.08729411764705881
Current ratio: 5.0252879021726224
Quick ratio: 4.747477145910008
Effective tax rate (%): 12.420886075949367
Interest coverage ratio: 0.9829351535836178
COGS to revenue (%): 25.364077669902912
R&D to revenue (%): 20.214979195561718
SG&A to revenue (%): 49.427877947295414
Free cash flow (dilution-adjusted): 986991.8699186994
Buyback yield (%): 0
Retained earnings: -26361517.615176152
Inventory turnover: 0.6252136752136752
Receivables turnover: 1.658901351740006
Capitalized R&D asset: 631978.3197831978
ROCI (R&D-adjusted, %): 2.4866563963711616
FCF margin (%): 31.570735090152567
Rule of 40 score: 31.570735090152567
Financial ratios for BWAY — quarterly report dated 2025-06-30
Total revenue: 3726253.687315634
Gross profit: 2802064.896755162
Operating income: 170501.4749262537
Net income: 597935.1032448377
Capital expenditures: 343952.802359882
Operating cash flow: 3652802.359882006
Depreciation & amortization: 114454.2772861357
Net tangible assets: 20097935.103244837
Owner earnings: 368436.57817109145
Return on net tangible assets (%): 1.8332061292784596
Capex to operating income (%): 201.73010380622833
Buffett classification: The Gruesome
Stock price: 6.57
P/E ratio: 293.61834299300267
Shares outstanding: 40129409
Book value: 20097935.103244834
P/B ratio: 13.118273881152767
Market cap (USD): 263650217.13000003
Debt to equity: 0.08997240650501968
Current ratio: 3.508311118080602
Quick ratio: 3.3440489258271917
Effective tax rate (%): 3.338102050548403
Interest coverage ratio: 0.7372448979591837
COGS to revenue (%): 24.802089930335654
R&D to revenue (%): 18.556048131728943
SG&A to revenue (%): 52.06618112729576
Free cash flow (dilution-adjusted): 3241887.9056047197
Buyback yield (%): 0
Retained earnings: -28096460.17699115
Inventory turnover: 0.7477326968973746
Receivables turnover: 3.2632394730043917
Capitalized R&D asset: 1114870.901983356
ROCI (R&D-adjusted, %): 1.587938573300273
Rosenberg metric: 0.7416893091880565
FCF margin (%): 87.00126662444585
Revenue growth (%): 19.19102033802608
Rule of 40 score: 106.19228696247193
Financial ratios for BWAY — quarterly report dated 2025-09-30
Total revenue: 4082175.2265861025
Gross profit: 3069184.290030211
Operating income: 378549.84894259815
Net income: 473111.78247734136
Capital expenditures: 241691.84290030212
Operating cash flow: 418731.1178247734
Depreciation & amortization: 122054.38066465256
Net tangible assets: 21167673.716012083
Owner earnings: 353474.3202416918
Return on net tangible assets (%): 1.669877970456005
Capex to operating income (%): 63.84676775738228
Buffett classification: The Good
Stock price: 7.53
P/E ratio: 220.39687549476767
Shares outstanding: 40129409
Book value: 21167673.716012083
P/B ratio: 14.275279079978592
Market cap (USD): 302174449.77
Debt to equity: 0.09636765860272604
Current ratio: 3.190589774169969
Quick ratio: 3.0206209364059555
Effective tax rate (%): 13.384955752212392
Interest coverage ratio: 2.1943957968476355
COGS to revenue (%): 24.8149792776791
R&D to revenue (%): 17.73238602723505
SG&A to revenue (%): 48.17939609236234
Free cash flow (dilution-adjusted): 67069.48640483385
Buyback yield (%): 0
Retained earnings: -28302416.918429002
Inventory turnover: 0.7589406971480307
Receivables turnover: 2.634431663092221
Capitalized R&D asset: 1395688.351593031
ROCI (R&D-adjusted, %): 1.516168696167634
Rosenberg metric: 0.3863202829361845
FCF margin (%): 1.642984014209592
Revenue growth (%): 9.551725919307223
Rule of 40 score: 11.194709933516815
Financial ratios for BWAY — quarterly report dated 2025-12-31
Total revenue: 4573899.371069182
Gross profit: 3496226.4150943393
Operating income: 602515.7232704402
Net income: 922327.0440251572
Capital expenditures: 396855.34591194964
Operating cash flow: -238679.24528301886
Depreciation & amortization: 110691.82389937107
Net tangible assets: 23025471.698113207
Owner earnings: 636163.5220125787
Return on net tangible assets (%): 2.762868575954986
Capex to operating income (%): 65.86638830897704
Buffett classification: The Good
Stock price: 9.51
P/E ratio: 166.40578086280274
Shares outstanding: 40129409
Book value: 23025471.69811321
P/B ratio: 16.574282802695944
Market cap (USD): 381630679.59
Debt to equity: 0.09310170579478563
Current ratio: 3.830212516356089
Quick ratio: 3.508324685286288
Effective tax rate (%): -15.426997245179063
Interest coverage ratio: 4.445475638051044
COGS to revenue (%): 23.561361292540393
R&D to revenue (%): 17.401168786524583
SG&A to revenue (%): 45.864558267445865
Free cash flow (dilution-adjusted): -326729.55974842765
Buyback yield (%): 0
Retained earnings: -28537106.918238994
Inventory turnover: 0.4803756658256237
Receivables turnover: 3.5380685964485528
Capitalized R&D asset: 1509079.8773918683
ROCI (R&D-adjusted, %): 2.2009825534530547
Rosenberg metric: 0.5899455066620468
FCF margin (%): -7.143348229632177
Revenue growth (%): 12.045640306682891
Rule of 40 score: 4.902292077050714
Financial ratios for BWAY — annual report dated 2025-12-31
Total revenue: 16422955.974842766
Gross profit: 12385534.591194969
Operating income: 1359433.9622641508
Net income: 2400314.465408805
Capital expenditures: 549371.0691823899
Operating cash flow: 5666666.666666666
Depreciation & amortization: 483647.7987421383
Net tangible assets: 23025471.698113207
Owner earnings: 2334591.1949685533
Return on net tangible assets (%): 10.139167725106185
Capex to operating income (%): 40.411751098774
Buffett classification: The Good
Stock price: 9.51
P/E ratio: 158.99195088382027
Shares outstanding: 40129409
Book value: 23025471.69811321
P/B ratio: 16.574282802695944
Market cap (USD): 381630679.59
Debt to equity: 0.09310170579478563
Current ratio: 3.830212516356089
Quick ratio: 3.508324685286288
Effective tax rate (%): 0.9987029831387809
Interest coverage ratio: 1.9569941149841557
COGS to revenue (%): 24.584011488750598
R&D to revenue (%): 18.38774533269507
SG&A to revenue (%): 48.750598372427
Free cash flow (dilution-adjusted): 4741194.968553459
Buyback yield (%): 0
Retained earnings: -28537106.918238994
Inventory turnover: 1.799691617605831
Receivables turnover: 12.703721722208709
Capitalized R&D asset: 4947202.412860976
ROCI (R&D-adjusted, %): 6.278110608461305
Rosenberg metric: 2.0342421777276263
FCF margin (%): 28.86931546194352
Revenue growth (%): 46.14733106147869
Rule of 40 score: 75.01664652342221
Financial ratios for CGEM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.43
Shares outstanding: 61458046
Market cap (USD): 948297649.78
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGEM — annual report dated 2022-12-31
Total revenue: 0
Operating income: -132137000
Net income: 111214000
Capital expenditures: 1042000
Operating cash flow: -126664000
Depreciation & amortization: 93000
Net tangible assets: 535029000
Owner earnings: 110265000
Return on net tangible assets (%): 20.609163241618678
Buffett classification: The Gruesome
Stock price: 10.55
P/E ratio: 5.830042848022732
Shares outstanding: 61458046
Book value: 535029000
P/B ratio: 1.2118640023251077
Market cap (USD): 648382385.3000001
Debt to equity: 0.009698539705324385
Current ratio: 21.089519068361632
Quick ratio: 21.089519068361632
Effective tax rate (%): 27.836448227550292
Free cash flow (dilution-adjusted): -155754000
Buyback yield (%): 0
Retained earnings: -47695000
Capitalized R&D asset: 91948000
ROCI (R&D-adjusted, %): -11.234069231871208
Rule of 40 score: 0
Financial ratios for CGEM — annual report dated 2023-12-31
Total revenue: 0
Operating income: -190649000
Net income: -153162000
Capital expenditures: 208000
Operating cash flow: -134275000
Depreciation & amortization: 310000
Net tangible assets: 453703000
Owner earnings: -153060000
Return on net tangible assets (%): -33.73572579418694
Buffett classification: The Gruesome
Stock price: 10.19
Shares outstanding: 61458046
Book value: 453895000
P/B ratio: 1.3797408844336245
Market cap (USD): 626257488.74
Debt to equity: 0.007909318234393416
Current ratio: 17.066176209261826
Quick ratio: 17.066176209261826
Free cash flow (dilution-adjusted): -164921000
Buyback yield (%): 0
Retained earnings: -200857000
Capitalized R&D asset: 209761160
ROCI (R&D-adjusted, %): -18.402903732021144
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.74
Shares outstanding: 61458046
Market cap (USD): 1028807690.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGEM — annual report dated 2024-12-31
Total revenue: 0
Operating income: -196919000
Net income: -167383000
Capital expenditures: 0
Operating cash flow: -145303000
Depreciation & amortization: 306000
Net tangible assets: 590328000
Owner earnings: -167077000
Return on net tangible assets (%): -28.302401376861674
Buffett classification: The Gruesome
Stock price: 12.18
Shares outstanding: 61458046
Book value: 590328000
P/B ratio: 1.268039124486726
Market cap (USD): 748559000.28
Debt to equity: 0.0036437370411025734
Current ratio: 13.530459751362287
Quick ratio: 13.530459751362287
Free cash flow (dilution-adjusted): -183127000
Buyback yield (%): 0
Retained earnings: -368240000
Capitalized R&D asset: 272510360
ROCI (R&D-adjusted, %): -21.035968385597307
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.18
Shares outstanding: 61458046
Market cap (USD): 748559000.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -54996000
Net income: -48501000
Capital expenditures: 0
Operating cash flow: -43155000
Depreciation & amortization: 76000
Net tangible assets: 551839000
Owner earnings: -48425000
Return on net tangible assets (%): -8.775204362141857
Buffett classification: The Gruesome
Stock price: 7.57
Shares outstanding: 61458046
Book value: 551839000
P/B ratio: 0.8430672863280776
Market cap (USD): 465237408.22
Debt to equity: 0.0033343058392031008
Current ratio: 11.619145124136166
Quick ratio: 11.619145124136166
Free cash flow (dilution-adjusted): -52529000
Buyback yield (%): 0
Retained earnings: -416741000
Capitalized R&D asset: 41459000
ROCI (R&D-adjusted, %): -4.607120462699276
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -75798000
Net income: -70055000
Capital expenditures: 0
Operating cash flow: -57609000
Depreciation & amortization: 77000
Net tangible assets: 492146000
Owner earnings: -69978000
Return on net tangible assets (%): -14.218951286813263
Buffett classification: The Gruesome
Stock price: 7.53
Shares outstanding: 61458046
Book value: 492146000
P/B ratio: 0.9403288584688284
Market cap (USD): 462779086.38
Debt to equity: 0.0030864824665851193
Current ratio: 9.833594696699693
Quick ratio: 9.833594696699693
Free cash flow (dilution-adjusted): -67496000
Buyback yield (%): 0
Retained earnings: -486796000
Capitalized R&D asset: 88807530
ROCI (R&D-adjusted, %): -8.420720689852368
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -55595000
Net income: -50610000
Capital expenditures: 0
Operating cash flow: -36877000
Depreciation & amortization: 79000
Net tangible assets: 451369000
Owner earnings: -50531000
Return on net tangible assets (%): -11.195053271270291
Buffett classification: The Gruesome
Stock price: 5.93
Shares outstanding: 61458046
Book value: 451369000
P/B ratio: 0.8074241092764456
Market cap (USD): 364446212.78
Debt to equity: 0.0026319928927329966
Current ratio: 10.447690569954514
Quick ratio: 10.447690569954514
Free cash flow (dilution-adjusted): -46382000
Buyback yield (%): 0
Retained earnings: -537406000
Capitalized R&D asset: 96539570
ROCI (R&D-adjusted, %): -11.275482209254974
Rule of 40 score: 0
Financial ratios for CGEM — annual report dated 2025-12-31
Total revenue: 0
Operating income: -241648000
Net income: -219879000
Capital expenditures: 49000
Operating cash flow: -175750000
Depreciation & amortization: 311000
Net tangible assets: 408730000
Owner earnings: -219617000
Return on net tangible assets (%): -53.731558730702424
Buffett classification: The Gruesome
Stock price: 10.35
Shares outstanding: 61458046
Book value: 408730000
P/B ratio: 1.5562615323073912
Market cap (USD): 636090776.1
Debt to equity: 0.006564235558926431
Current ratio: 10.247635197795502
Quick ratio: 10.247635197795502
Free cash flow (dilution-adjusted): -211839000
Buyback yield (%): 0
Retained earnings: -588119000
Capitalized R&D asset: 332038490
ROCI (R&D-adjusted, %): -28.77894235579179
Rule of 40 score: 0
Financial ratios for CGEM — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -55259000
Net income: -50713000
Capital expenditures: 11000
Operating cash flow: -38109000
Depreciation & amortization: 79000
Net tangible assets: 408730000
Owner earnings: -50645000
Return on net tangible assets (%): -12.390820345949649
Buffett classification: The Gruesome
Stock price: 10.35
Shares outstanding: 61458046
Book value: 408730000
P/B ratio: 1.5562615323073912
Market cap (USD): 636090776.1
Debt to equity: 0.006564235558926431
Current ratio: 10.247635197795502
Quick ratio: 10.247635197795502
Free cash flow (dilution-adjusted): -45432000
Buyback yield (%): 0
Retained earnings: -588119000
Capitalized R&D asset: 91203460
ROCI (R&D-adjusted, %): -12.147715745218406
Rule of 40 score: 0
Financial ratios for CLNN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 82
Shares outstanding: 12778307
Market cap (USD): 1047821174
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNN — annual report dated 2022-12-31
Total revenue: 473000
Gross profit: 447000
Operating income: -44557000
Net income: -29918000
Capital expenditures: 5179000
Operating cash flow: -39011000
Depreciation & amortization: 1019000
Net tangible assets: 3237000
Owner earnings: -34078000
Return on net tangible assets (%): -1052.764905776954
Buffett classification: The Gruesome
Stock price: 20
Shares outstanding: 12778307
Book value: 3237000
P/B ratio: 78.95154155081865
Market cap (USD): 255566140
Debt to equity: 9.831325301204819
Current ratio: 2.106877390488562
Quick ratio: 2.1037742657140797
Interest coverage ratio: -13.518507281553399
COGS to revenue (%): 5.496828752642706
R&D to revenue (%): 6748.414376321352
SG&A to revenue (%): 3417.1247357293873
Free cash flow (dilution-adjusted): -52703000
Buyback yield (%): 0
Retained earnings: -193219000
Inventory turnover: 0.6046511627906976
Receivables turnover: 0.15947403910991234
Capitalized R&D asset: 31920000
ROCI (R&D-adjusted, %): -37.20985996547094
FCF margin (%): -11142.28329809725
Rule of 40 score: -11142.28329809725
Financial ratios for CLNN — annual report dated 2023-12-31
Total revenue: 654000
Gross profit: 533000
Operating income: -38260000
Net income: -49504000
Capital expenditures: 330000
Operating cash flow: -30171000
Depreciation & amortization: 1705000
Net tangible assets: 13390000
Owner earnings: -48129000
Return on net tangible assets (%): -359.4398805078417
Buffett classification: The Gruesome
Stock price: 6
Shares outstanding: 12778307
Book value: 13390000
P/B ratio: 5.725903061986558
Market cap (USD): 76669842
Debt to equity: 2.401867064973861
Current ratio: 1.5338333991314648
Quick ratio: 1.5323726806158706
Interest coverage ratio: -8.394032470381747
COGS to revenue (%): 18.501529051987767
R&D to revenue (%): 4075.6880733944954
SG&A to revenue (%): 1962.3853211009173
Free cash flow (dilution-adjusted): -39618000
Buyback yield (%): 0
Retained earnings: -242723000
Inventory turnover: 3.27027027027027
Receivables turnover: 0.48878923766816146
Capitalized R&D asset: 48041400
ROCI (R&D-adjusted, %): -41.47768758893786
Rosenberg metric: 0.0026942355889724313
FCF margin (%): -6057.798165137615
Revenue growth (%): 38.266384778012686
Rule of 40 score: -6019.531780359603
Financial ratios for CLNN — quarterly report dated 2024-09-30
Capital expenditures: 1000
Buffett classification: The Gruesome
Stock price: 4.59
Shares outstanding: 12778307
Market cap (USD): 58652429.129999995
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNN — quarterly report dated 2024-12-31
Capital expenditures: 1000
Buffett classification: The Gruesome
Stock price: 5.31
Shares outstanding: 12778307
Market cap (USD): 67852810.17
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CLNN — annual report dated 2024-12-31
Total revenue: 342000
Gross profit: 272000
Operating income: -31975000
Net income: -39400000
Capital expenditures: 15000
Operating cash flow: -21326000
Depreciation & amortization: 1645000
Net tangible assets: -8857000
Owner earnings: -37770000
Buffett classification: The Gruesome
Stock price: 5.31
Shares outstanding: 12778307
Book value: -8857000
Market cap (USD): 67852810.17
Debt to equity: -2.353279891611155
Current ratio: 1.5700126323972403
Quick ratio: 1.5634049169176951
Interest coverage ratio: -7.867864173228346
COGS to revenue (%): 20.46783625730994
R&D to revenue (%): 5864.912280701754
SG&A to revenue (%): 3633.6257309941525
Free cash flow (dilution-adjusted): -29294000
Buyback yield (%): 0
Retained earnings: -282123000
Inventory turnover: 1.0294117647058822
Receivables turnover: 0.8746803069053708
Capitalized R&D asset: 48450450
ROCI (R&D-adjusted, %): -58.2138421242678
Rosenberg metric: -0.009791783905458639
FCF margin (%): -8565.497076023392
Revenue growth (%): -47.706422018348626
Rule of 40 score: -8613.203498041741
Financial ratios for CLNN — quarterly report dated 2025-03-31
Total revenue: 81000
Gross profit: 61000
Operating income: -3571000
Net income: -751000
Capital expenditures: 0
Operating cash flow: -5011000
Depreciation & amortization: 404000
Net tangible assets: -4973000
Owner earnings: -347000
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 12778307
Book value: -4973000
Market cap (USD): 39357185.56
Debt to equity: -4.21093907098331
Current ratio: 1.3629691564474173
Quick ratio: 1.3594388703084355
Interest coverage ratio: -5.873355263157895
COGS to revenue (%): 24.691358024691358
R&D to revenue (%): 1828.395061728395
SG&A to revenue (%): 3016.0493827160494
Free cash flow (dilution-adjusted): -6958000
Buyback yield (%): 0
Retained earnings: -282874000
Inventory turnover: 0.5263157894736842
Receivables turnover: 0.053606882859033755
Capitalized R&D asset: 1481000
ROCI (R&D-adjusted, %): -16.116690578670493
FCF margin (%): -8590.123456790125
Rule of 40 score: -8590.123456790125
Financial ratios for CLNN — quarterly report dated 2025-06-30
Total revenue: 27000
Gross profit: 27000
Operating income: -5628000
Net income: -7419000
Capital expenditures: 0
Operating cash flow: -4744000
Depreciation & amortization: 366000
Net tangible assets: -8550000
Owner earnings: -7053000
Buffett classification: The Gruesome
Stock price: 3.91
Shares outstanding: 12778307
Book value: -8550000
Market cap (USD): 49963180.370000005
Debt to equity: -2.43812865497076
Current ratio: 1.582387113810404
Quick ratio: 1.5719566939529972
Interest coverage ratio: -8.288659793814434
COGS to revenue (%): 0
R&D to revenue (%): 13014.814814814816
SG&A to revenue (%): 8122.222222222223
Free cash flow (dilution-adjusted): -6111000
Buyback yield (%): 0
Retained earnings: -290293000
Inventory turnover: 0
Receivables turnover: 0.02047005307050796
Capitalized R&D asset: 4506270
ROCI (R&D-adjusted, %): -19.829702785341237
Rosenberg metric: -0.022957461174881837
FCF margin (%): -22633.333333333336
Revenue growth (%): -66.66666666666666
Rule of 40 score: -22700.000000000004
Financial ratios for CLNN — quarterly report dated 2025-09-30
Total revenue: 15000
Gross profit: 15000
Operating income: -5373000
Net income: -8777000
Capital expenditures: 11000
Operating cash flow: -3992000
Depreciation & amortization: 365000
Net tangible assets: -12357000
Owner earnings: -8423000
Buffett classification: The Gruesome
Stock price: 6.03
Shares outstanding: 12778307
Book value: -12357000
Market cap (USD): 77053191.21000001
Debt to equity: -1.7246904588492353
Current ratio: 1.5257645075848785
Quick ratio: 1.5184204189742354
Interest coverage ratio: -8.2788906009245
COGS to revenue (%): 0
R&D to revenue (%): 23420
SG&A to revenue (%): 13213.333333333332
Free cash flow (dilution-adjusted): -5706000
Buyback yield (%): 0
Retained earnings: -299070000
Inventory turnover: 0
Receivables turnover: 0.02727272727272727
Capitalized R&D asset: 6356110
ROCI (R&D-adjusted, %): -23.063575610563472
Rosenberg metric: -0.003414911781445646
FCF margin (%): -38040
Revenue growth (%): -44.44444444444444
Rule of 40 score: -38084.444444444445
Financial ratios for CLNN — quarterly report dated 2025-12-31
Total revenue: 77000
Gross profit: 54000
Operating income: -7244000
Net income: -9226000
Capital expenditures: 28000
Operating cash flow: -4799000
Depreciation & amortization: 360000
Net tangible assets: -17592000
Owner earnings: -8894000
Buffett classification: The Gruesome
Stock price: 5.87
Shares outstanding: 12778307
Book value: -17592000
Market cap (USD): 75008662.09
Debt to equity: -1.2319804456571168
Current ratio: 0.8330549368968078
Quick ratio: 0.8296213808463252
Interest coverage ratio: -9.710455764075068
COGS to revenue (%): 29.87012987012987
R&D to revenue (%): 7146.7532467532465
SG&A to revenue (%): 2353.246753246753
Free cash flow (dilution-adjusted): -6192000
Buyback yield (%): 0
Retained earnings: -308296000
Inventory turnover: 0.6216216216216216
Receivables turnover: 0.13050847457627118
Capitalized R&D asset: 9016330
ROCI (R&D-adjusted, %): -36.14652362799276
Rosenberg metric: 0.011101622544833475
FCF margin (%): -8041.558441558442
Revenue growth (%): 413.33333333333337
Rule of 40 score: -7628.225108225109
Financial ratios for CLNN — annual report dated 2025-12-31
Total revenue: 200000
Gross profit: 157000
Operating income: -21816000
Net income: -26173000
Capital expenditures: 39000
Operating cash flow: -18546000
Depreciation & amortization: 1495000
Net tangible assets: -17592000
Owner earnings: -24717000
Buffett classification: The Gruesome
Stock price: 5.87
Shares outstanding: 12778307
Book value: -17592000
Market cap (USD): 75008662.09
Debt to equity: -1.2319804456571168
Current ratio: 0.8330549368968078
Quick ratio: 0.8296213808463252
Interest coverage ratio: -8.134228187919463
COGS to revenue (%): 21.5
R&D to revenue (%): 7005.500000000001
SG&A to revenue (%): 4215
Free cash flow (dilution-adjusted): -24967000
Buyback yield (%): 0
Retained earnings: -308296000
Inventory turnover: 1.162162162162162
Receivables turnover: 0.3389830508474576
Capitalized R&D asset: 36246010
ROCI (R&D-adjusted, %): -64.32496250277994
Rosenberg metric: -0.0057333732176687606
FCF margin (%): -12483.5
Revenue growth (%): -41.52046783625731
Rule of 40 score: -12525.020467836257
Financial ratios for CWL.TO — annual report dated 2021-08-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.619047619047619
Shares outstanding: 29481964
Market cap (USD): 47732703.61904762
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWL.TO — annual report dated 2022-08-31
Total revenue: 119209923.66412213
Gross profit: 26449618.320610687
Operating income: 10077099.23664122
Net income: 6242748.091603053
Capital expenditures: 355725.19083969464
Operating cash flow: 5420610.6870229
Depreciation & amortization: 1959541.9847328244
Net tangible assets: 19806870.22900763
Owner earnings: 7846564.885496182
Return on net tangible assets (%): 39.61536979226886
Capex to operating income (%): 3.5300356033633817
Buffett classification: The Great
Stock price: 1.3358778625954197
P/E ratio: 6.308808632917583
Shares outstanding: 29481964
Book value: 26767175.57251908
P/B ratio: 1.4713656637672894
Market cap (USD): 39384303.05343511
Debt to equity: 0.6314558676743193
Current ratio: 1.3898881377756318
Quick ratio: 1.3898881377756318
Effective tax rate (%): 23.64145658263305
Interest coverage ratio: 31.505966587112173
COGS to revenue (%): 77.81257003810073
SG&A to revenue (%): 13.734191400121665
Free cash flow (dilution-adjusted): 5052671.755725191
Buyback yield (%): 0
Retained earnings: 4966412.213740458
Receivables turnover: 5.093942655837166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.960257413688147
FCF margin (%): 4.238465725354593
Rule of 40 score: 4.238465725354593
Financial ratios for CWL.TO — annual report dated 2023-08-31
Total revenue: 72445185.18518518
Gross profit: 12015555.555555554
Operating income: -2220000
Net income: -8372592.592592592
Capital expenditures: 123703.7037037037
Operating cash flow: -8313333.333333333
Depreciation & amortization: 1979259.259259259
Net tangible assets: 12124444.444444444
Owner earnings: -6517037.037037036
Return on net tangible assets (%): -53.751221896383186
Buffett classification: The Gruesome
Stock price: 0.6592592592592592
Shares outstanding: 29481964
Book value: 20536296.29629629
P/B ratio: 0.9464344236040977
Market cap (USD): 19436257.748148147
Debt to equity: 0.7862862501803494
Current ratio: 1.315211187214612
Quick ratio: 1.315211187214612
Interest coverage ratio: -3.3374164810690425
COGS to revenue (%): 83.41428001758673
SG&A to revenue (%): 19.65010582713878
Free cash flow (dilution-adjusted): -8612592.592592593
Buyback yield (%): 0
Retained earnings: -3553333.333333333
Receivables turnover: 4.587288930581614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.041851463591646
FCF margin (%): -11.888426498706558
Revenue growth (%): -39.22889726085065
Rule of 40 score: -51.11732375955721
Financial ratios for CWL.TO — annual report dated 2024-08-31
Total revenue: 64556296.29629629
Gross profit: 13105185.185185185
Operating income: -681481.4814814815
Net income: 3102222.222222222
Capital expenditures: 340740.74074074073
Operating cash flow: 912592.5925925926
Depreciation & amortization: 1532592.5925925926
Net tangible assets: 15445925.925925925
Owner earnings: 4294074.074074074
Return on net tangible assets (%): 27.800690581239206
Buffett classification: The Gruesome
Stock price: 0.762962962962963
P/E ratio: 7.250817316141357
Shares outstanding: 29481964
Book value: 23797037.037037034
P/B ratio: 0.945228877544668
Market cap (USD): 22493646.607407406
Debt to equity: 0.2023905870634377
Current ratio: 1.3084373793280988
Quick ratio: 1.3084373793280988
Effective tax rate (%): 32.98127700432069
Interest coverage ratio: -1.2867132867132869
COGS to revenue (%): 79.69960184048375
SG&A to revenue (%): 21.35603722275132
Free cash flow (dilution-adjusted): 380000
Buyback yield (%): 0
Retained earnings: -451111.11111111107
Receivables turnover: 4.66048128342246
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.4418728102770997
FCF margin (%): 0.5886335211299929
Revenue growth (%): -10.889459207983558
Rule of 40 score: -10.300825686853566
Financial ratios for CWL.TO — quarterly report dated 2024-11-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7142857142857143
Shares outstanding: 29481964
Market cap (USD): 21058545.714285716
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CWL.TO — quarterly report dated 2025-02-28
Total revenue: 16081944.444444446
Gross profit: 3333333.3333333335
Operating income: -450694.44444444444
Net income: -146527.77777777778
Capital expenditures: 50694.444444444445
Operating cash flow: -3156250
Depreciation & amortization: 320833.3333333334
Net tangible assets: 15010416.666666668
Owner earnings: 123611.11111111115
Buffett classification: The Gruesome
Stock price: 0.6041666666666667
Shares outstanding: 29481964
Book value: 23271527.777777776
P/B ratio: 0.7653996801050402
Market cap (USD): 17812019.916666668
Debt to equity: 0.1859389454209066
Current ratio: 1.3880751782242384
Quick ratio: 1.3880751782242384
Interest coverage ratio: -6.555555555555555
COGS to revenue (%): 79.27282148717507
SG&A to revenue (%): 23.52966577424648
Free cash flow (dilution-adjusted): -3252083.3333333335
Buyback yield (%): 0.02339244333972435
Retained earnings: -349305.55555555556
Receivables turnover: 1.0359203757548647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6714311468232508
FCF margin (%): -20.221953536574834
Rule of 40 score: -20.221953536574834